PHGE BiomX Inc: Enterprise Value-to-Revenue Multiple

Public company logo of BiomX Inc (PHGE)

BiomX Inc. (PHGE) profitability is based on the creation of phage cocktails to combat antibiotic resistance. On GURU.Markets, the EV/Sales trend illustrates market value relative to revenue, where 63696.97 shows the value of this parameter. The company's environmental strategy relies on strict biomaterial disposal and energy conservation. High clinician confidence confirms its status as an innovative pioneer in the therapy of dangerous infections.

PHGE: BiomX Inc Enterprise Value-to-Revenue Ratio 11/23/2025 - 09/11/2026

BiomX Inc - analytical breakdowns and key metrics (PHGE)

- market price and analyst price targets:
- company stock capitalization data:
Initial company analysis:PHGE, BiomX Ltd
Flagship merchandise of BiomX

This indicator measures the total business value, including debt and cash, relative to sales volume, allowing for an assessment of the asset's real price without distortions from the credit load. For BiomX Inc. (PHGE) and its unique phage therapy patents, the Enterprise Value to Sales ratio demonstrates the extent to which the market prices future revenue growth into the current capitalization, confirming capital stability.